Celltrion
068270.KS
#823
Rank
HK$236.88 B
Marketcap
HK$1,083
Share price
0.49%
Change (1 day)
31.09%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Half-year Reports

Thumbnail Celltrion
 Half-year Report 2025-h1

Half-year Report 2025-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2023-h1

Half-year Report 2023-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2022-h1

Half-year Report 2022-h1

Language: English

View Half-year Report
Thumbnail Celltrion
 Half-year Report 2021-h1

Half-year Report 2021-h1

Language: English

View Half-year Report